JP2021513543A5 - - Google Patents

Download PDF

Info

Publication number
JP2021513543A5
JP2021513543A5 JP2020543112A JP2020543112A JP2021513543A5 JP 2021513543 A5 JP2021513543 A5 JP 2021513543A5 JP 2020543112 A JP2020543112 A JP 2020543112A JP 2020543112 A JP2020543112 A JP 2020543112A JP 2021513543 A5 JP2021513543 A5 JP 2021513543A5
Authority
JP
Japan
Prior art keywords
group
substituent
substituted
alkyl group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020543112A
Other languages
English (en)
Japanese (ja)
Other versions
JP7412004B2 (ja
JP2021513543A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/074771 external-priority patent/WO2019154412A1/zh
Publication of JP2021513543A publication Critical patent/JP2021513543A/ja
Publication of JP2021513543A5 publication Critical patent/JP2021513543A5/ja
Application granted granted Critical
Publication of JP7412004B2 publication Critical patent/JP7412004B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020543112A 2018-02-10 2019-02-11 抗菌剤化合物 Active JP7412004B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201810138645.X 2018-02-10
CN201810138645 2018-02-10
CN201810320980 2018-04-11
CN201810320980.1 2018-04-11
PCT/CN2019/074771 WO2019154412A1 (zh) 2018-02-10 2019-02-11 作为抗菌素的化合物

Publications (3)

Publication Number Publication Date
JP2021513543A JP2021513543A (ja) 2021-05-27
JP2021513543A5 true JP2021513543A5 (cg-RX-API-DMAC7.html) 2021-12-02
JP7412004B2 JP7412004B2 (ja) 2024-01-12

Family

ID=67548785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020543112A Active JP7412004B2 (ja) 2018-02-10 2019-02-11 抗菌剤化合物

Country Status (7)

Country Link
US (1) US11498909B2 (cg-RX-API-DMAC7.html)
EP (1) EP3750881A4 (cg-RX-API-DMAC7.html)
JP (1) JP7412004B2 (cg-RX-API-DMAC7.html)
KR (1) KR102868718B1 (cg-RX-API-DMAC7.html)
CN (1) CN112074507B (cg-RX-API-DMAC7.html)
SG (1) SG11202007665RA (cg-RX-API-DMAC7.html)
WO (1) WO2019154412A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020061375A1 (en) 2018-09-20 2020-03-26 Forge Therapeutics, Inc. Antibacterial compounds
WO2021195260A1 (en) 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor and methods of making
WO2021195258A1 (en) * 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor, formulations, and uses thereof
WO2023015236A2 (en) * 2021-08-04 2023-02-09 The Research Foundation For The State University Of New York Composition and method for treatment of gram negative bacterial infection
AR127139A1 (es) 2021-09-28 2023-12-20 Forge Therapeutics Inc Inhibidores de lpxc y usos de estos
CA3242454A1 (en) 2021-12-24 2023-06-29 Intervet International B.V. Process of the preparation of hydroxylamine derivatives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2387803T3 (es) 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
CA2691987C (en) 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
WO2010017060A1 (en) 2008-08-04 2010-02-11 Schering Corporation Urea derivatives as antibacterial agents
JP5793766B2 (ja) * 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なn−結合型ヒドロキサム酸誘導体
RS59255B1 (sr) 2010-04-20 2019-10-31 Fujifilm Toyama Chemical Co Ltd Derivat hidroksaminske kiseline
US9738604B2 (en) 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
EP2638006A1 (en) 2010-11-10 2013-09-18 Achaogen, Inc. Hydroxamic acid derivatives and their use in the treatment of bacterial infections
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AU2014306451B2 (en) 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
CN105777464B (zh) * 2014-12-26 2020-09-29 中国科学院上海药物研究所 异羟肟酸衍生物及其制备方法和应用
AU2017257755B2 (en) 2016-04-25 2021-05-06 Duke University Benzoylglycine derivatives and methods of making and using same
JP7082445B2 (ja) 2016-12-23 2022-06-08 インターベット インターナショナル ベー. フェー. ウシ又はブタの呼吸器疾患を治療するための化合物
US11034650B2 (en) 2016-12-23 2021-06-15 Intervet Inc. Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection

Similar Documents

Publication Publication Date Title
JP2024514837A5 (cg-RX-API-DMAC7.html)
JP2024543512A5 (cg-RX-API-DMAC7.html)
RU2403258C2 (ru) Тиазолилдигидроиндазолы
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2019512485A5 (cg-RX-API-DMAC7.html)
IL283592B2 (en) Inhibitors of apol1 and methods of using same
JP2019532928A5 (cg-RX-API-DMAC7.html)
JP2022544714A5 (cg-RX-API-DMAC7.html)
RU2020105929A (ru) Способы и композиции для модулирования сплайсинга
JP2006501181A5 (cg-RX-API-DMAC7.html)
JP2010506854A5 (cg-RX-API-DMAC7.html)
JP2023535453A5 (cg-RX-API-DMAC7.html)
JP2022500392A5 (cg-RX-API-DMAC7.html)
JP2020521766A5 (cg-RX-API-DMAC7.html)
JP2015519322A5 (cg-RX-API-DMAC7.html)
JP2023520462A5 (cg-RX-API-DMAC7.html)
CN109790145A (zh) 二氢嘧啶类化合物及其制备方法和用途
JP2025508971A5 (cg-RX-API-DMAC7.html)
JP2024534420A5 (cg-RX-API-DMAC7.html)
JP2026503618A5 (cg-RX-API-DMAC7.html)
JP2017513852A5 (cg-RX-API-DMAC7.html)
RU2008119994A (ru) Ингибиторы калиевых каналов
WO2011056744A4 (en) IRE-1 α INHIBITORS
JP2023533616A5 (cg-RX-API-DMAC7.html)
JP2021514399A5 (cg-RX-API-DMAC7.html)